Dian Diagnostics Group Co.,Ltd. (SHE:300244)
China · Delayed Price · Currency is CNY 18.36
-0.10 (-0.54%)
Sep 1, 2026, 3:04 PM CST
Dian Diagnostics Group Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 11,281 | 9,686 | 6,941 | 14,881 | 15,754 | 20,829 | |
Market Cap Growth | 5.55% | 39.54% | -53.35% | -5.54% | -24.37% | -2.07% |
Enterprise Value | 13,658 | 12,955 | 11,653 | 19,072 | 20,099 | 24,657 |
Last Close Price | 18.46 | 15.56 | 10.95 | 21.34 | 22.35 | 29.73 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 42.36 | 219.87 | - | 48.40 | 10.99 | 17.91 |
Forward PE | 24.61 | 22.81 | 11.41 | 11.88 | 8.08 | 15.56 |
PS Ratio | 1.14 | 0.96 | 0.57 | 1.11 | 0.78 | 1.59 |
PB Ratio | 1.31 | 1.13 | 0.79 | 1.50 | 1.66 | 2.79 |
P/TBV Ratio | 1.87 | 1.61 | 1.15 | 2.24 | 2.40 | 4.61 |
P/FCF Ratio | 6.42 | 5.56 | 8.22 | 12.20 | 22.78 | 28.60 |
P/OCF Ratio | 5.61 | 4.78 | 5.75 | 7.75 | 9.61 | 15.80 |
PEG Ratio | - | 2.19 | 0.32 | 1.10 | 0.38 | 0.71 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 1.38 | 1.28 | 0.96 | 1.42 | 0.99 | 1.89 |
EV/EBITDA Ratio | 10.59 | 16.61 | 12.36 | 13.00 | 4.73 | 9.99 |
EV/EBIT Ratio | 15.06 | 26.21 | 21.33 | 18.82 | 5.50 | 11.59 |
EV/FCF Ratio | 7.77 | 7.43 | 13.80 | 15.64 | 29.06 | 33.85 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.26 | 0.31 | 0.41 | 0.42 | 0.63 | 0.58 |
Debt / EBITDA Ratio | 1.72 | 2.83 | 3.09 | 2.46 | 1.34 | 1.66 |
Debt / FCF Ratio | 1.26 | 1.52 | 4.23 | 3.44 | 8.66 | 5.99 |
Net Debt / Equity Ratio | 0.03 | 0.01 | 0.16 | 0.08 | 0.14 | 0.23 |
Net Debt / EBITDA Ratio | 0.24 | 0.13 | 1.44 | 0.55 | 0.32 | 0.71 |
Net Debt / FCF Ratio | 0.16 | 0.06 | 1.61 | 0.66 | 1.94 | 2.40 |
Asset Turnover | 0.69 | 0.67 | 0.72 | 0.69 | 1.11 | 0.94 |
Inventory Turnover | 4.61 | 4.56 | 5.61 | 6.29 | 9.26 | 6.60 |
Quick Ratio | 2.15 | 2.17 | 2.08 | 2.41 | 1.93 | 1.38 |
Current Ratio | 2.66 | 2.66 | 2.54 | 2.82 | 2.17 | 1.63 |
Return on Equity (ROE) | 4.47% | 1.68% | -1.81% | 5.99% | 21.94% | 21.97% |
Return on Assets (ROA) | 3.92% | 2.04% | 2.02% | 3.25% | 12.47% | 9.50% |
Return on Invested Capital (ROIC) | 6.72% | 2.98% | 5.25% | 6.85% | 26.69% | 21.55% |
Return on Capital Employed (ROCE) | 9.10% | 4.80% | 4.90% | 7.80% | 27.50% | 23.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 2.36% | 0.46% | -5.15% | 2.07% | 9.10% | 5.58% |
FCF Yield | 15.57% | 18.00% | 12.16% | 8.20% | 4.39% | 3.50% |
Dividend Yield | 1.80% | 2.25% | 8.22% | 0.28% | 0.90% | 0.45% |
Payout Ratio | 112.62% | 580.66% | - | 97.78% | 20.70% | 22.88% |
Buyback Yield / Dilution | 0.18% | 0.98% | 1.30% | -0.18% | 0.02% | -0.43% |
Total Shareholder Return | 1.98% | 3.23% | 9.52% | 0.10% | 0.92% | 0.03% |